ArticleFuture medicinal chemistry2022
Latest progress in the development of cyclooxygenase-2 pathway inhibitors targeting microsomal prostaglandin E
Krista LaBorde et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it